Gedeon Richter Plc., Budapest/Hungary, is a major pharmaceutical company in Central Eastern Europe, with an expanding direct presence in Western Europe, China and Latin America. Richter’s consolidated sales were approximately EUR 1.56 billion in 2019, reaching a market capitalisation of EUR 4.1 billion. Richter’s product portfolio covers many important therapeutic areas, including Women’s Healthcare and Central Nervous System. Richter is also active in biologic product development, and committed to bringing biosimilar products to global markets.